Get started
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD)SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD)SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD)

SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD)

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0RG8 chart

Key stats

Market capitalization
‪20.40 B‬EUR
Dividend yield (indicated)
0.33%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
2.75EUR
Net income
‪309.70 M‬EUR
Revenue
‪2.78 B‬EUR
Shares float
‪29.47 M‬
Beta (1Y)
1.82

About SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD)

Sector
Health Technology
Industry
Medical Specialties
CEO
René Fáber
Website
sartorius.com
Headquarters
Aubagne
Employees (FY)
‪10.66 K‬
Founded
1978
ISIN
FR0013154002
FIGI
BBG00CVVGPD3
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0RG8 is 200.70 EUR — it has decreased by 4.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stocks are traded under the ticker 0RG8.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) is going to release the next earnings report on Jul 19, 2024. Keep track of upcoming events with our Earnings Calendar.
0RG8 stock is 7.68% volatile and has beta coefficient of 1.82. Check out the list of the most volatile stocks — is SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) there?
One year price forecast for SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) has a max estimate of 360.00 EUR and a min estimate of 150.00 EUR.
0RG8 earnings for the last quarter are 0.72 EUR per share, whereas the estimation was 0.80 EUR resulting in a −9.63% surprise. The estimated earnings for the next quarter are 0.90 EUR per share. See more details about SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) earnings.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) revenue for the last quarter amounts to ‪706.40 M‬ EUR despite the estimated figure of ‪679.21 M‬ EUR. In the next quarter revenue is expected to reach ‪718.95 M‬ EUR.
Yes, you can track SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financials in yearly and quarterly reports right on TradingView.
0RG8 stock has fallen by 22.39% compared to the previous week, the month change is a 23.83% fall, over the last year SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) has showed a 23.43% decrease.
0RG8 net income for the last quarter is ‪56.10 M‬ EUR, while the quarter before that showed ‪39.80 M‬ EUR of net income which accounts for 40.95% change. Track more SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financial stats to get the full picture.
Today SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) has the market capitalization of ‪19.52 B‬, it has decreased by 1.35% over the last week.
Yes, 0RG8 dividends are paid annually. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 0.72%. Tracking SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) dividends might help you take more informed decisions.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) dividend yield was 0.29% in 2023, and payout ratio reached 20.53%. The year before the numbers were 0.48% and 15.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0RG8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock right from TradingView charts — choose your broker and connect to your account.
0RG8 reached its all-time high on Sep 10, 2021 with the price of 550.00 EUR, and its all-time low was 50.75 EUR and was reached on Oct 17, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪10.66 K‬ employees. See our rating of the largest employees — is SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock shows the strong sell signal. See more of SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) future price: according to them, 0RG8 price has a max estimate of 360.00 EUR and a min estimate of 150.00 EUR. Read a more detailed SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) forecast: see what analysts think of SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) and suggest that you do with its stocks.